ARCHIVES

NCI renews Roswell Park’s core grant for five years.

This article is from The Cancer Letter archive.

Vol. 29 No. 35 | September 26, 2003

Download PDF Visit The Full Archive

Related Articles

In Brief: UK Scientist Receives Pezcoller Award; Yale Appoints Associate Director for Trials

January 19, 1996

In Brief: ACS Board Names McGinnis Prsident; Fuller Re-Elected chairman; Lenhard Is Vice President

November 25, 1994

FOLFOX 4 Should Be First-Line Therapy For Advanced Disease, NCCTG Finds

December 26, 2003

Combined analysis moves Herceptin to adjuvant setting in breast cancer.

May 27, 2005

NCCN Also to Warn Doctors. Amgen’s Pledges to Disclose Future Results.

February 23, 2007

NCI “Community Cancer Centers” Program in Development, House Report Reveals.

June 30, 2006